Simplicity Wealth,Llc Compass Therapeutics, Inc. Transaction History
Simplicity Wealth,Llc
- $1.2 Billion
- Q1 2025
A detailed history of Simplicity Wealth,Llc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Simplicity Wealth,Llc holds 46,543 shares of CMPX stock, worth $82,846. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,543Holding current value
$82,846% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
90Shares Held
93.7MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$39.8 Million0.88% of portfolio
-
Blackstone Inc New York, NY10MShares$17.8 Million0.07% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.57MShares$15.3 Million1.86% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$11.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.99MShares$10.7 Million0.02% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $180M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...